/PRNewswire/ Exopharm Limited (ASX:EX1) has been granted US patent US 11202805 for its LEAP™ exosome purification technology. This patent positions Exopharm.
BIT225 administered orally significantly reduced viral load in the lungs and blood of animals challenged with SARS-CoV-2. BIT225 protected against severe.